Translocation (2;3) in hematologic malignancies.
Cytogenetic studies have revealed nonrandom involvement of some chromosomes in specific structural abnormalities in human neoplasias. In this report we present three patients with t(2;3) associated with hematologic malignancies, and review the pertinent literature. These findings lead us to regard the region between 3q26 and 3q29 as implicated in chromosomal changes in these disorders, whereas, no vulnerable point has been observed in chromosome #2. We suggest that these translocations may activate genes on chromosome #3 related to these neoplasias.
Slavutsky
I
I
de Vinuesa
M L
ML
Larripa
I
I
Dupont
J
J
de Salum
S B
SB
D000208:Acute Disease; D000328:Adult; D002900:Chromosomes, Human, 1-3; D005260:Female; D005819:Genetic Markers; D006689:Hodgkin Disease / Q000235:genetics; D006801:Humans; D007621:Karyotyping; D007938:Leukemia / Q000235:genetics*; D008223:Lymphoma / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D014178:Translocation, Genetic
D005819:Genetic Markers